*Danaparoid Sodium: A Review of Its Use in Hepatic Thrombotic Disorders DOI: http://dx.doi.org/10.5772/intechopen.103851*

#### **Table 2.**

*Some characteristics of SOS and TA-TMA after HSCT compared.*

It is clear that both antithrombotic and immune modulating drugs are indicated to prevent or treat both conditions. However, prevention is always better than cure if the right product is available. The ability of a single product to attenuate the effects of both systems without causing further damage would be a desirable bonus especially if this can be done safely and relatively cheaply.
